These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23095969)

  • 61. Stress-hyperglycemia, insulin and immunomodulation in sepsis.
    Marik PE; Raghavan M
    Intensive Care Med; 2004 May; 30(5):748-56. PubMed ID: 14991101
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacologic treatment related to severe sepsis.
    Powers J; Jacobi J
    AACN Adv Crit Care; 2006; 17(4):423-32; quiz 434. PubMed ID: 17091042
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Cortisone substitution in sepsis. Is less more?].
    Briegel J
    Anaesthesist; 2003 Dec; 52 Suppl 1():S24-31. PubMed ID: 14727048
    [No Abstract]   [Full Text] [Related]  

  • 64. Evolution of Sepsis Management: From Early Goal-Directed Therapy to Personalized Care.
    Head LW; Coopersmith CM
    Adv Surg; 2016 Sep; 50(1):221-34. PubMed ID: 27520874
    [No Abstract]   [Full Text] [Related]  

  • 65. Adherence to surviving sepsis guidelines among pediatric intensivists. A national survey.
    Thabet FC; Zahraa JN; Chehab MS
    Saudi Med J; 2017 Jun; 38(6):609-615. PubMed ID: 28578440
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Use of inotropes and vasopressor agents in critically ill patients.
    Bangash MN; Kong ML; Pearse RM
    Br J Pharmacol; 2012 Apr; 165(7):2015-33. PubMed ID: 21740415
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine.
    Crit Care Med; 1999 Mar; 27(3):639-60. PubMed ID: 10199548
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Helping children survive sepsis.
    Duffy MK; Moloney-Harmon PA
    Nursing; 2015 Feb; 45(2):34-40; quiz 40-1. PubMed ID: 25533156
    [No Abstract]   [Full Text] [Related]  

  • 69. The Surviving Sepsis Campaign Bundle: 2018 Update.
    Levy MM; Evans LE; Rhodes A
    Crit Care Med; 2018 Jun; 46(6):997-1000. PubMed ID: 29767636
    [No Abstract]   [Full Text] [Related]  

  • 70. A users' guide to the 2016 Surviving Sepsis Guidelines.
    Dellinger RP; Schorr CA; Levy MM
    Intensive Care Med; 2017 Mar; 43(3):299-303. PubMed ID: 28101604
    [No Abstract]   [Full Text] [Related]  

  • 71. Sepsis: Current Definition, Pathophysiology, Diagnosis, and Management.
    Taeb AM; Hooper MH; Marik PE
    Nutr Clin Pract; 2017 Jun; 32(3):296-308. PubMed ID: 28537517
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sepsis management and the pediatric surgeon.
    Boomer LA; Feliz A
    Semin Pediatr Surg; 2019 Feb; 28(1):67-72. PubMed ID: 30824138
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The use of steroids in children with septicemia: review of the literature and assessment of current practice in PICUs in the UK.
    Hildebrandt T; Mansour M; Al Samsam R
    Paediatr Anaesth; 2005 May; 15(5):358-65. PubMed ID: 15828985
    [No Abstract]   [Full Text] [Related]  

  • 74. Vasopressor and Inotrope Use in Canadian Emergency Departments: Evidence Based Consensus Guidelines.
    Djogovic D; MacDonald S; Wensel A; Green R; Loubani O; Archambault P; Bordeleau S; Messenger D; Szulewski A; Davidow J; Kircher J; Gray S; Smith K; Lee J; Marc Benoit J; Howes D
    CJEM; 2015 Feb; 17 Suppl 1():1-16. PubMed ID: 26067924
    [No Abstract]   [Full Text] [Related]  

  • 75. Guideline promotes early, aggressive sepsis treatment to boost survival.
    Kuehn BM
    JAMA; 2013 Mar; 309(10):969-70. PubMed ID: 23483148
    [No Abstract]   [Full Text] [Related]  

  • 76. Trends in agents used for the management of sepsis.
    Littleton MT
    Crit Care Nurs Q; 1993 Feb; 15(4):33-46. PubMed ID: 8431793
    [No Abstract]   [Full Text] [Related]  

  • 77. Vasopressor and inotrope use in Canadian emergency departments: evidence based consensus guidelines.
    Djogovic D; MacDonald S; Wensel A; Green R; Loubani O; Archambault P; Bordeleau S; Messenger D; Szulewski A; Davidow J; Kircher J; Gray S; Smith K; Lee J; Benoit JM; Howes D
    CJEM; 2015 Jan; 17(1):1-2. PubMed ID: 25961083
    [No Abstract]   [Full Text] [Related]  

  • 78. Sepsis in the older person: The ravages of time and bacteria.
    Burkett E; Macdonald SP; Carpenter CR; Arendts G; Hullick C; Nagaraj G; Osborn TM
    Emerg Med Australas; 2018 Apr; 30(2):249-258. PubMed ID: 29569846
    [No Abstract]   [Full Text] [Related]  

  • 79. Advancements in the pharmacological management of sepsis in the elderly.
    Psarrakis C; Giamarellos-Bourboulis EJ
    Expert Opin Pharmacother; 2023; 24(10):1171-1187. PubMed ID: 37166074
    [TBL] [Abstract][Full Text] [Related]  

  • 80. New therapies for sepsis.
    Cunnington A; Nadel S
    Curr Top Med Chem; 2008; 8(7):603-14. PubMed ID: 18473886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.